Search Results

268 items found for ""

Blog Posts (81)

  • Management of Gender Reassignment Patients -- Dr. Robert T. Sataloff

    Dr. Robert T. Sataloff has been working with transgender and other LGBTQ patients since 1975 when he was an intern at the University of Michigan. When Dr. Sataloff returned to Philadelphia in 1980, he established the world's first comprehensive, multidisciplinary voice center that included not only laryngologists, but also speech-language pathologists and singing voice specialists. The voice center has grown to include three speech-language pathologists and singing voice specialists, acting voice specialists, nurse clinicians, voice scientists, psychological professionals, and collaborating Arts Medicine personnel in other medical disciplines including endocrinology, pulmonology, neurology, gastroenterology, various surgical specialties and other fields. Closely collaborating, multidisciplinary team structure is essential to provide optimal voice care for the LGBTQ population, as well as for other voice patients. Read Dr. Sataloff's publication in Professional Voice, The Science and Art of Clinical Care on Management of Gender Reassignment Patients Robert T. Sataloff, MD, DMA, FACS is Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery and Senior Associate Dean for Clinical Academic Specialties, Drexel University College of Medicine. He also holds Adjunct Professorships in the Departments of Otolaryngology – Head and Neck Surgery at Thomas Jefferson University, Temple University and the Philadelphia College of Osteopathic Medicine; and he is on the faculty of the Academy of Vocal Arts. He serves as Conductor of the Thomas Jefferson University Choir. Dr. Sataloff is also a professional singer and singing teacher. He holds an undergraduate degree from Haverford College in Music Theory and Composition; graduated from Jefferson Medical College, Thomas Jefferson University; received a Doctor of Musical Arts in Voice Performance from Combs College of Music; and he completed Residency in Otolaryngology - Head and Neck Surgery and a Fellowship in Otology, Neurotology and Skull Base Surgery at the University of Michigan. Dr. Sataloff is Chairman of the Boards of Directors of the Voice Foundation and of the American Institute for Voice and Ear Research. He also has served as Chairman of the Board of Governors of Graduate Hospital; President of the American Laryngological Association, the International Association of Phonosurgery, the Pennsylvania Academy of Otolaryngology – Head and Neck Surgery, and The American Society of Geriatric Otolaryngology, and in numerous other leadership positions. Dr. Sataloff is Editor-in-Chief of the Journal of Voice; Editor Emeritus of Ear, Nose and Throat Journal; Associate Editor of the Journal of Singing; on the Editorial Board of Medical Problems of Performing Artists, and is an editorial reviewer for numerous otolaryngology journals. He has written over 1,000 publications including 70 books, and he has been awarded more than $5 million in research funding. His H-index is 43 (as of July 2021). He has invented more than 75 laryngeal microsurgical instruments distributed currently by Integra Medical, ossicular replacement prostheses produced by Grace Medical, and a novel laryngeal prosthesis (patent pending). He holds a patent on a unique thyroplasty implant. His medical practice is limited to care of the professional voice and to otology/neurotology/skull base surgery. Dr. Sataloff has developed numerous novel surgical procedures including total temporal bone resection for formerly untreatable skull base malignancy, laryngeal microflap and mini-microflap procedures, vocal fold lipoinjection, vocal fold lipoimplantation, and others. Dr. Sataloff is recognized as one of the founders of the field of voice, having written the first modern comprehensive article on care of singers, and the first chapter and book on care of the professional voice, as well as having influenced the evolution of the field through his own efforts and through the Voice Foundation for over 4 decades. Dr. Sataloff has been recognized by Best Doctors in America (Woodward White Athens) every year since 1992, Philadelphia Magazine since 1997, and Castle Connolly’s “America’s Top Doctors” since 2002.

  • Joining Forces to Advance Medical Innovation, Education And Care

    Israel’s ALYN Hospital Pediatric & Adolescent Rehabilitation Center and Philadelphia International Medicine Join Forces to Advance Medical Innovation, Education And Care -- The ALYN-PIM Health Gateway Initiative is a collaborative program aimed at delivering medical education, joint research, and patient care -- Jerusalem, Israel, and Philadelphia, November 7, 2021. ALYN Hospital Pediatric & Adolescent Rehabilitation Center, a leading healthcare provider in Israel, and Philadelphia International Medicine (PIM), a provider of specialized clinical services and education from world-renowned Philadelphia area hospitals, have established the ALYN-PIM Health Gateway Initiative to advance education, research, innovation, and patient care including second opinion activities. “Medical education, research, and innovation are ongoing activities at ALYN, bringing considerable benefits not only to our staff but primarily to our patients,” said Dr. Maurit Beeri, Director General of ALYN Hospital. “By partnering with PIM, we can build a valuable health gateway, connecting our medical teams and professionals. We are looking forward to identifying and developing collaborative initiatives, such as physician exchanges, research projects, and more.” “We are very excited to be working with ALYN and for the many opportunities that lie ahead,” said Edgar Vesga, CEO and President of PIM. “It is important to us that we can continue to make quality medical care available to international patients, and we see cooperation between centers of excellence in Philadelphia and Jerusalem as an ideal way to achieve this goal. Connecting Israel with Philadelphia opens many doors for both PIM and ALYN to collaborate in future endeavors to improve the future of medicine.” The ALYN-PIM Health Gateway initiative will focus on sharing medical knowledge and technology, while improving accessibility to highly skilled care. By building relationships and jointly exploring opportunities, ALYN and PIM seek to improve the overall medical status of their communities. ALYN and PIM will continuously grow this initiative to identify and develop additional opportunities, including physician exchanges, lectures and programs in hospital administration, consulting projects, training in best practices, and more. About ALYN ALYN Jerusalem is one of the leading healthcare providers in Israel, dedicated to providing the best quality of medical and rehabilitation treatment for children facing physical challenges, both congenital and acquired. ALYN enables them to function to the best of their ability and integrate into their family life within the framework of a supportive community. ALYN is affiliated with the Hebrew University Faculty of Medicine and offers advanced care from birth to adulthood. With more than 90 years of experience, it is now one of the world leaders in Pediatric Rehabilitation. https://www.alyn.org/ About PIM PIM provides international patients and physicians with access to an unmatched network of world-renowned doctors, surgeons and hospitals that deliver personalized medical, surgical and rehabilitative care ranked among the best in the world. PIM is owned and operated by Thomas Jefferson University Hospital, Temple University Hospital, and Fox Chase Cancer Center and affiliated with Wills Eye Hospital, Rothman Institute, Main Line Health, Nemours Children’s Health, Magee Rehabilitation Hospital, the Vincera Institute, and the Renfrew Center. https://www.philadelphiamedicine.com/ Contact Shirel Daniel Senior Manager of Global Outreach sdaniel@philadelphiamedcine.com

  • The New Era of Medical Tourism and Hospitality

    Join us for a webinar on November 8th at 8:00PM. Featured speakers Bonnie Grant, Dr. Maria Cecilia Aponte and Dr. Ignazio Marino will discuss the future of this exciting industry! Philadelphia International Medicine is proud to be hosting this event with Temple University School of Sport, Tourism and Hospitality Management. REGISTER HERE!! Speakers Bonnie Grant, Executive Director, PHL Life Sciences As Executive Director, Bonnie is responsible for marketing Greater Philadelphia, ranked the second largest life sciences sector in the country, as “America’s Life Sciences Meetings Destination.” She manages more than 60 regional life sciences leaders from Pennsylvania, New Jersey and Delaware, leveraging common resources to enhance awareness of the region as a vibrant destination for life sciences meetings and conventions. Representing public, private and academic entities, members of the Congress assist with sales, on-site services and sponsorship efforts, as well as promoting the region’s premier attractions in history, science, arts, culture and entertainment, all making for a unique and memorable Philadelphia convention experience. For more than two decades, Bonnie has promoted Philadelphia to residents and visitors in positions with government, corporate and educational institutions. For nine years, she served as Deputy City Representative for the City of Philadelphia under the administrations of Mayors Edward G. Rendell and John F. Street. She has also served as director of communications and spokesperson for Greater Philadelphia Urban Affairs Coalition; the Philadelphia Eagles; and Chestnut Hill College. Dr. Maria Cecilia Aponte, International Accounts Manager, The Panama Clinic Dr. Maria Cecilia Aponte is physician, specialized in Health Services, Marketing, and Management with 15 years of experience. Dr. Aponte has had leadership, management and advisory roles in the pharmaceutical industry, health insurance and service delivery. Dr. Aponte currently leads the international department of The Panama Clinic and positioning of Panama in the international scope with the city’s Chamber of Commerce. Her international experience includes USA, Mexico, Panama, Salvador, Guatemala, Costa Rica, Honduras, Venezuela, Ecuador, Chile, Peru, Aruba, Curazao, St Maarten, and Germany, Panama. Dr. Ignazio Marino Professor of Surgery, Sidney Kimmel Medical College EVP, International Innovative Strategic Ventures Executive Director, Jefferson Italy Center Ignazio R. Marino, MD, ScD is executive vice president of Jefferson International Innovative Strategic Ventures. He is a trailblazer in transplant medicine who has also held high public office as a senator of the Republic of Italy and mayor of Rome. Dr. Marino has performed more than 650 transplants and was a member of the surgical team that performed the only baboon-to-human liver xenotransplants in medical history, and he performed the first transplant in Italy on an HIV-positive patient. He has authored more than 700 scientific publications and four scientific books, and has served on the editorial boards of “Transplantation,” “Liver Transplantation,” “Digestive Diseases and Sciences,” and 15 other international scientific journals. He has also published on the religious, bioethical, and humanitarian aspects of medicine, including a monograph on the future of the Italian national healthcare system. In 2006, he was elected senator of the Republic of Italy and appointed chair of the Standing Health Committee of the Italian Senate and later, chair within the senate of the Investigative Committee on the National Healthcare System. Dr. Marino was elected mayor of Rome in 2013 and served until 2015. REGISTER HERE!!

View All

Pages (187)

  • Pulmonology | Philadelphia International Medicine

    Pulmonology Specialties Cardiology Button Button Button Button Neurology Oncology Pediatrics Transplant Ophthalmology Orthopedics Rehabilitation Urology Pulmonology Women's Health What We Offer Philadelphia International Medicine is home to one of the nation’s premier lung-disease research centers, we offer patients access to leading-edge clinical trials and innovative treatment options. Our partners also have one of the most active lung-transplant programs in the United States, with nationally renowned transplant surgeons. Even if you’ve been told you have no options, our skilled network of specialists may be able to help you. Innovation & Research ​ ​ ​ ​ ​ Specialty Physicians Daniel A. Salerno, MD, MS Gerard J. Criner, MD, FACP, FACCP Norihisa Shigemura, MD, PhD Out of gallery VIEW OUR NETWORK HOSPITALS GETTING STARTED

  • Retina

    Ophthalmology Retina WHAT IS IT Retinal diseases are a range of disorders that affect the thin layer of tissue lining the back of the eye. The retina, which is responsible for receiving light and converting it into neural signals for the brain, is one of the most important parts of the eye. RETINAL DETACHMENT: A retinal detachment is a separation of the retina from the underlying layers of the eye wall. MACULAR DEGENERATION: Macular degeneration affects people age 50 years and older and is associated with central vision loss. DIABETIC RETINOPATHY: Diabetic Retinopathy is caused by the elevated blood sugar damaging the small blood vessels in the retina. RETINAL VEIN OCCLUSION: Retinal vein occlusion is a blockage in the blood vessel of your eye that can result in sight loss. SYMPTOMS Sudden appearance of floaters in the vision Blurred vision Flashes of light in one or both eyes “Shadow” over visual field Loss of vision TREATMENTS Vitrectomy. When the vitreous causes a retinal detachment or fills with blood causing poor vision, the vitreous — a clear, jelly-like substance within the eyeball — may need to be removed during a vitrectomy. During this procedure, the surgeon creates a small incision in the wall of the eye and removes the vitreous with a tiny vacuum cutter, and the fluid is replaced with natural salt water. The goal is to help improve visual acuity. Some will experience mild discomfort or redness for a few days after the surgery, which can be relieved by over the counter or prescription pain medication. Scleral buckle surgery. Sometimes used to treat retinal detachment [link to retinal detachment condition page], scleral buckle surgery involves the surgeon attaching a small piece of silicone rubber to the outside of the white of the eye. Once in place, the buckle lightly squeezes the eye so that the detached retina returns back into place. Pneumatic retinopexy. During this procedure to treat some types of retinal tears, a surgeon will inserts a gas bubble into the eye to gently push the retina back into place. The bubble is eventually absorbed by the fluid within the eye. Laser photocoagulation procedures use a laser beam to permanently weld the retina to the wall of the eye. Cryopexy procedures apply a freezing probe to the outside of the eye, and the freezing penetrates into the eye. The retinal tear is frozen inside the eye, and scar tissue anchors the retina in place. * During vitrectomy, scleral buckle surgery or pneumatic retinopexy, the surgeon will usually perform additional procedures to seal the retina in place and to ensure that it does not tear again. These secondary surgeries are known as laser photocoagulation and cryopexy. WHAT TO EXPECT Retinal issues are serious, and most require immediate medical and surgical attention from an ophthalmologist. Because every retinal problem is unique, each patient requires an individualized approach. BENEFITS OF GOING HERE WILLS EYE HOSPITAL Our retinal specialist team has pioneered the clinical care, research efforts, and development of all major innovations in retina care for 60 years. These highly-skilled and experienced surgeons have been intimately involved in the development of most of the treatments for many retinal diseases, including the latest treatments for macular degeneration and diabetic retinopathy. Our Network PIM Globe Icon Specialties Cardiology Button Button Button Button Neurology Oncology Pediatrics Transplant

  • Brain Tumor

    Neurology Brain Tumor WHAT IS IT Meningiomas – tumors that begin in the meninges, three thin layers of tissue covering the brain and spinal cord Malignant tumors – including glioblastomas, oligodendromas and astrocytomas Metastatic lesions – tumors caused by cancer located elsewhere in the body SYMPTOMS Frequent headaches; Changes in hearing, vision or sense of smell and touch; Fatigue; Loss of balance; Memory loss; Mood swings or change in personality; Muscle weakness; Nausea; Numbness on one side of your body; Seizures; Speech difficulty; Vomiting TREATMENTS MAIN LINE HEALTH Surgery: Surgery options include robotic and computer guided surgery that enables surgeons to make smaller openings so there is less trauma and recovery. Sometimes, surgery is all that is needed to fully remove a brain tumor. Chemotherapy: This treatment is necessary for higher-grade tumors and also when surgeons are unable to remove all of a tumor due to its size and location. Some tumors may respond to chemotherapy alone, without surgery. Radiation Therapy: Traditional external beam radiation may be used in combination with chemotherapy for high-grade tumors or those that surgeons cannot fully remove. In addition, Main Line Health offers the latest in internal beam radiation to target tumors more closely. JEFFERSON HEALTH Brachytherapy – destroys tumors by implanting radioactive medicine directly to or near the treatment site Chemotherapy – reaches cancer that may have spread, even microscopically, throughout the body Craniotomy – surgical procedure that removes a bone flap, a section of the skull, to access the brain Intensity-modulated radiation therapy – uses computer technology to deliver radiation treatment that precisely fits the size and shape of the tumor Minimally invasive cranial base surgery – uses smaller incisions and specially designed instruments to eliminate a tumor while saving surrounding tissue from damage Stereotactic radiosurgery & radiotherapy – a noninvasive procedure that applies large doses of radiation directly to a tumor WHAT TO EXPECT Living with a brain tumor can be difficult. Aside from the symptoms you may experience, you must also deal with the side effects from treatments. Medical advancements over the last 20 years have significantly increased the survival rate of patients with brain tumors and helped them to live longer following diagnosis. At Main Line Health, we are not only here to offer you the very best possible treatments, but to answer any questions you may have and to help you navigate all your options during this difficult time. We offer support and palliative care to address your physical, emotional and social needs during this time. Some palliative care treatments include: Anti-seizure medication Corticosteroids to lower swelling in the brain Emotional support Nutritional support Relaxation techniques Our goal is to help reduce your symptoms and improve your quality of life so you can make the most of your time and reach the fullest possible recovery. BENEFITS OF GOING HERE MAIN LINE HEALTH New techonologies, quick diagnosis: At Main Line Health, we have the latest diagnostic techniques so we can assess your symptoms and make an accurate diagnosis quickly. Full range of treatment options: The Main Line Health brain cancer specialists also take into consideration your personal preferences when it comes to treatment planning. We will explain all of your options fully and work with you to provide the best possible care plan for your individual situation. JEFFERSON HEALTH Top-ranked neouroscience and cancer care for brain tumors; At Jefferson Health, our team of experts can guide you from diagnosis through treatment and recovery using the latest, most advanced therapies and expertise in surgery and brain tumor treatment. As the area’s only dedicated neuroscience hospital, our specialists treat the highest volume of brain tumors in the region, including meningiomas, malignant and benign tumors and metastatic lesions. Bringing together the expertise and experience of the Vickie and Jack Farber Institute for Neuroscience and the Sidney Kimmel Cancer Center, our team has also helped many patients navigate life after a brain tumor diagnosis, and can provide you with the support and care you need. Advanced treatment: We apply scientific discoveries and breakthroughs to provide individualized treatment plans. Innovation: First hospital in the region to provide Gamma Knife and the only in the region offering the latest Gamma Knife — an ultraprecise form of radiosurgery. NCI-designated: We’re one of the National Cancer Institute’s 70 designated cancer centers in the nation — noted for our research and delivering cutting-edge treatments to patients. Leaders in radiosurgery. Coordinated care: Our multidisciplinary team of experts work together to create a seamless experience for patients and their families. Our Network PIM Globe Icon Specialties Cardiology Button Button Button Button Neurology Oncology Pediatrics Transplant

View All